Publications by authors named "Ming-Ye Lv"
Clin Rheumatol
August 2022
Article Synopsis
- Thrombotic thrombocytopenic purpura (TTP) is a serious condition marked by severe anemia, low platelet counts, and organ damage, with forms that are either congenital due to a genetic mutation or acquired, with systemic lupus erythematosus (SLE) being a major cause of the acquired type.
- SLE-TTP may resist standard treatments like plasma exchange and high-dose steroids, often requiring new biological therapies like belimumab, which targets B-lymphocytes and is the first approved treatment for SLE in 50 years.
- A case study of a 28-year-old woman with SLE-TTP showed successful treatment using belimumab after plasma exchanges, leading to positive outcomes
